142 related articles for article (PubMed ID: 452604)
1. [The significance of biogenic amines in cerebral infarction (author's transl)].
Jellinger K; Riederer P; Kothbauer P
Wien Klin Wochenschr; 1979 May; 91(10):339-44. PubMed ID: 452604
[No Abstract] [Full Text] [Related]
2. [Amines in mental disorders (author's transl)].
Takahashi R
Tanpakushitsu Kakusan Koso; 1977; 22(6):815-21. PubMed ID: 337391
[No Abstract] [Full Text] [Related]
3. The effect of two synthetic ACTH analogues on the metabolism of biogenic amines in the rat brain.
Leonard BE
Arch Int Pharmacodyn Ther; 1974 Feb; 207(2):242-53. PubMed ID: 4363855
[No Abstract] [Full Text] [Related]
4. Changes of some putative neurotransmitters in human cerebral infarction.
Jellinger K; Riederer P; Kothbauer P
J Neural Transm Suppl; 1978; (14):31-44. PubMed ID: 39976
[TBL] [Abstract][Full Text] [Related]
5. [Cerebral ischemia and changes in the brain monoamines].
Kogure K
No To Shinkei; 1983 Jan; 35(1):33-9. PubMed ID: 6197078
[No Abstract] [Full Text] [Related]
6. [Neurotransmitters in the cerebrospinal fluid (author's transl)].
Takeoka T
No To Shinkei; 1981 Sep; 33(9):927-46. PubMed ID: 6172140
[No Abstract] [Full Text] [Related]
7. [Current biochemical conceptions of mental diseases. II. Role of changes in the biogenic amine system in the pathogenesis of affective disorders].
Anokhina IP; Gamaleia NB
Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(6):921-30. PubMed ID: 6158209
[No Abstract] [Full Text] [Related]
8. Pharmacological properties of new cyclic derivatives of phenylsuccinimide and their influence on noradrenaline, dopamine, serotonin, 5-hydroxyindoleacetic acid, gamma-aminobutyric acid concentrations and monoaminooxidase activity in animal brains.
Chmielewska B
Pharmazie; 1984 Apr; 39(4):259-62. PubMed ID: 6204346
[TBL] [Abstract][Full Text] [Related]
9. [Variations of cerebral biogenic amines after injection of 4-butyrolactone].
Nouaille-Degorce J; Riotte M; Barras B; Pegon Y; Cier A
C R Seances Soc Biol Fil; 1971; 165(7):1676-81. PubMed ID: 4261929
[No Abstract] [Full Text] [Related]
10. [Biochemical aspects of human behaviour (author's transl)].
Ambrozi L; Birkmayer W; Danielczyk W; Neumayer E; Riederer P
Folia Clin Int (Barc); 1973 Sep; 23(9):565-87. PubMed ID: 4616856
[No Abstract] [Full Text] [Related]
11. Concentration of biogenic amines and their metabolites in different parts of brain after experimental cerebral concussion.
Kmieciak-Kołada K; Felińska W; Stachura Z; Majchrzak H; Herman ZS
Pol J Pharmacol Pharm; 1987; 39(1):47-53. PubMed ID: 2444951
[TBL] [Abstract][Full Text] [Related]
12. [Cerebral metabolic activator (author's transl)].
Ishihara N; Gotoh F
No To Shinkei; 1979 Aug; 31(8):739-49. PubMed ID: 40583
[No Abstract] [Full Text] [Related]
13. Further studies on monoamine metabolism in three regions of mouse brain during pregnancy: monoamine metabolite concentrations and the effects of injected hormones.
Greengrass PM; Tonge SR
Arch Int Pharmacodyn Ther; 1974 Nov; 212(1):48-59. PubMed ID: 4451418
[No Abstract] [Full Text] [Related]
14. Effects of methylmercury on brain biogenic amines in the developing rat pup.
Taylor LL; DiStefano V
Toxicol Appl Pharmacol; 1976 Dec; 38(3):489-97. PubMed ID: 13517
[No Abstract] [Full Text] [Related]
15. [Biogenic amines and effective disorders (author's transl)].
Takahashi R
Tanpakushitsu Kakusan Koso; 1981 Aug; 26(11):1798-808. PubMed ID: 6171015
[No Abstract] [Full Text] [Related]
16. [Biogenic amines to the pathophysiology of involuntary movements and cerebellar ataxia (author's transl)].
Ando K
Tanpakushitsu Kakusan Koso; 1981 Aug; 26(11):1772-80. PubMed ID: 6458067
[No Abstract] [Full Text] [Related]
17. The effect of pronounced hypoglycemia on monoamine metabolism in rat brain.
Agardh CD; Carlsson A; Linqvist M; Siesjö BK
Diabetes; 1979 Sep; 28(9):804-9. PubMed ID: 467805
[No Abstract] [Full Text] [Related]
18. The effect of methiothepin on cerebral monoamine neurons.
Lloyd KG; Bartholini G
Adv Biochem Psychopharmacol; 1974; 10():305-9. PubMed ID: 4846546
[No Abstract] [Full Text] [Related]
19. The monoamine oxidases of brain: selective inhibition with drugs and the consequences for the metabolism of the biogenic amines.
Yang HY; Neff NH
J Pharmacol Exp Ther; 1974 Jun; 189(3):733-40. PubMed ID: 4843170
[No Abstract] [Full Text] [Related]
20. Studies on psychotropic drugs. XX. Effects of 1-methyl-5-o-chlorophenyl-7-ethyl-1,2-dihydro-3H-thieno[2,3-e][1,4]diazepin-2-one (Y-6047) on the metabolism of biogenic amines.
Nakanishi M; Setoguchi M
Arzneimittelforschung; 1972 Nov; 22(11):1914-8. PubMed ID: 4267010
[No Abstract] [Full Text] [Related]
[Next] [New Search]
